The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure

Detalles Bibliográficos
Autores principales: Giraudo, C., Guarnieri, G., Molena, B., Caminati, M., Stramare, R., Vianello, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304153/
https://www.ncbi.nlm.nih.gov/pubmed/35963831
http://dx.doi.org/10.1016/j.pulmoe.2022.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304153/
https://www.ncbi.nlm.nih.gov/pubmed/35963831
http://dx.doi.org/10.1016/j.pulmoe.2022.07.003

Ejemplares similares